Arlington, TX, United States of America

Paul R Hallen


Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Arlington, TX (US) (1997)
  • Keller, TX (US) (2005)

Company Filing History:


Years Active: 1997-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul R Hallen: Innovator in Medical Device Technology

Introduction

Paul R Hallen is a notable inventor based in Arlington, TX (US), recognized for his contributions to medical device technology. With a total of 2 patents, Hallen has made significant strides in the field of ophthalmology, particularly in the treatment of central retinal vein occlusions.

Latest Patents

Hallen's latest patents include the "Laminar cribosa puncture device, methods related to use of such a device and methods for treating central retinal vein occlusions." This innovative device is designed for puncturing tissue in the body, specifically the lamina cribosa. The device aims to minimize damage to adjacent tissues while facilitating effective treatment of central retinal vein occlusions. The puncture member is configured to disrupt connective tissue surrounding the central retinal vein, allowing for repeated puncturing to strip or locally disrupt the tissue.

Career Highlights

Hallen is currently employed at Alcon Laboratories, Inc., where he continues to develop and refine medical devices that enhance patient care. His work focuses on creating solutions that improve surgical outcomes and patient safety.

Collaborations

Hallen collaborates with esteemed colleagues such as James R Dennewill and Russell L Finlay, contributing to a dynamic team dedicated to advancing medical technology.

Conclusion

Paul R Hallen's innovative work in medical devices, particularly in the treatment of eye conditions, showcases his commitment to improving healthcare solutions. His patents reflect a deep understanding of both technology and patient needs, marking him as a significant figure in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…